首页> 外文期刊>International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group >Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy
【24h】

Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy

机译:癌干样细胞/肿瘤起始细胞中应激反应基因的组成型表达和激活:癌症干细胞治疗的潜在目标

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer stem-like cells (CSCs)/tumour-initiating cells (TICs) are defined as the small population of cancer cells that have stem cell-like phenotypes and high capacity for tumour initiation. These cells may have a huge impact in the field of cancer therapy since they are extremely resistant to standard chemoradiotherapy and thus are likely to be responsible for disease recurrence after therapy. Therefore, extensive efforts are being made to elucidate the pathological and molecular properties of CSCs/TICs and, with this information, to establish efficient anti-CSC/TIC targeting therapies. This review considers recent findings on stress response genes that are preferentially expressed in CSCs/TICs and their roles in tumour-promoting properties. Implications for a novel therapeutic strategy targeting CSCs/TICs are also discussed.
机译:癌症干细胞样(CSCs)/肿瘤启动细胞(TICs)被定义为具有干细胞样表型和高肿瘤启动能力的少量癌细胞。这些细胞在癌症治疗领域可能会产生巨大影响,因为它们对标准放化疗有极强的抵抗力,因此可能导致治疗后的疾病复发。因此,正在作出大量努力以阐明CSCs / TIC的病理和分子特性,并利用该信息来建立有效的抗CSC / TIC靶向疗法。这篇综述考虑了有关在CSCs / TICs中优先表达的应激反应基因的最新发现及其在促肿瘤特性中的作用。还讨论了针对CSCs / TICs的新型治疗策略的含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号